Corify Care has announced the publication of its proprietary Global Volumetric Mapping technology in Nature Communications Medicine, marking a major advance in cardiac electrophysiology.
The technology is the first to map all four chambers of the heart simultaneously, delivering a complete, real-time view of cardiac arrhythmias in a single heartbeat.
Conventional mapping systems assess one heart chamber at a time, requiring clinicians to extrapolate unseen electrical activity. Corify Care’s Global Volumetric Mapping overcomes this limitation by enabling whole-heart visualisation, including activity within the cardiac walls and septum.
The system provides single-beat, three-dimensional maps that show how arrhythmias propagate across chambers and through myocardial tissue, both before and during ablation procedures.
Built as an evolution of Corify’s surface-mapping technology, the new platform is designed to support more precise diagnosis and treatment of complex arrhythmias. By revealing pathways that may be located deep within the heart wall or span multiple chambers, the technology aims to reduce blind spots, streamline workflows, and improve procedural efficiency in electrophysiology (EP) labs.
The Global Volumetric Mapping approach is positioned to support next-generation EP labs by enabling faster clinical decision-making and more targeted ablation strategies. Its non-invasive, whole-heart perspective has implications for managing challenging arrhythmia cases while potentially reducing procedure time and complexity.
Corify Care’s ACORYS® system is CE marked and is currently under review by the U.S. Food and Drug Administration. The company is also working on integrations with leading catheter navigation platforms to enable hybrid workflows, alongside ongoing research initiatives in volumetric analysis. Clinical data related to atrial fibrillation and ventricular tachycardia are scheduled to be presented at the AF Symposium 2026 in Boston.
Also Read